Position in JNJ
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$4,394,188
+$1,000,384 QoQ
Shares Held
17,302
+24.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.51%
of 13F equity value
Holder Rank
#1,709
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Almanack Investment Partners, LLC. holds $13,733,094 across 8 Drug Manufacturers - General names. JNJ ranks #1 (32.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
17,302 | $4,394,188 | |
| 2 | LLY |
ELI LILLY & Co
|
2,607 | $3,126,914 | |
| 3 | MRK |
Merck & Co., Inc.
|
14,048 | $1,805,168 | |
| 4 | ABBV |
AbbVie Inc.
|
5,322 | $1,339,228 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
14,979 | $863,089 | |
| 6 | AMGN |
Amgen Inc
|
2,375 | $860,035 | |
| 7 | NVS |
Novartis AG
|
4,703 | $737,054 | |
| 8 | PFE |
Pfizer Inc
|
25,225 | $607,418 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,394,188 | 17,302 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $3,393,804 | 13,884 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,885,089 | 13,941 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $2,424,181 | 13,074 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,541,094 | 10,089 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $1,100,016 | 6,633 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $948,996 | 6,562 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,078,995 | 6,658 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $948,870 | 6,492 | Shares | Sole | 2024-10-23 | |
| 2024-03-31 | $1,017,161 | 6,430 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $995,299 | 6,350 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,050,689 | 6,746 | Shares | Sole | 2023-10-05 | |
| 2023-06-30 | $1,321,842 | 7,986 | Shares | Sole | 2023-10-04 | |
| 2023-03-31 | $1,244,495 | 8,029 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $862,758 | 4,884 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,858,383 | 11,376 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $1,977,106 | 11,138 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,187,727 | 12,344 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,219,120 | 12,972 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,143,105 | 13,270 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $2,001,261 | 12,148 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,175,500 | 13,237 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,976,378 | 12,558 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $1,630,682 | 10,953 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,307,437 | 9,297 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $884,996 | 6,749 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||